tradmap

PNTG Pennant Group, Inc.

$40.56 -2.73%

Data as of close

Healthcare · Services-Health Services

Pennant Group, Inc. (PNTG) is a healthcare company in the Services-Health Services industry, with a market capitalization of $1.4 billion. Shares last traded at $40.56, 6.1% below their 52-week high. Over the past year the stock is up 64.5%. PNTG trades at a price-to-earnings ratio of 43.84, below the Services-Health Services median of 96.60. Net profit margin is 2.9%, above the peer median of 0.5%. Revenue grew 36.3% year over year.

Market Cap
$1.4B
Shares Out
34.9M
EPS (TTM)
$0.91
P/E (TTM)*
43.84
P/S Ratio
1.29
P/B Ratio
3.50
Dividend / Share
—
Dividend Yield
—
52-Week High
$43.21
52-Week Low
$22.50
Volume (venue)
16,053
Avg Vol (3m, venue)
16,215.46

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-4.79%
1M
+3.14%
3M
+5.20%
6M
+30.46%
YTD
+44.29%
1Y
+64.54%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
47.71
SMA (50)
$40.00
SMA (200)
$35.49
Price vs SMA50
+1.39%
Price vs SMA200
+14.28%
ATR (14)
$1.38

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$1.1B
Net Income
$32M
Gross Margin
—
Operating Margin
5.6%
Net Margin
2.9%
Return on Equity
8.0%
Return on Assets
3.1%
Current Ratio
1.20
Debt / Equity
0.48
Revenue Growth (YoY)
+36.3%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.25 2026-08-05
Q1 2026 $0.24 2026-05-06
Q4 2025 (derived) $0.25 2026-02-26
FY 2025 $0.84 2026-02-26
Q3 2025 $0.17 2025-11-05
Q2 2025 $0.20 2025-08-06

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-Health Services peers

PNTG vs 13 industry peers (Services-Health Services), by market cap. Data as of close

P/E vs peers
43.84 / 96.60 med
-55% discount
P/S vs peers
1.29 / 1.42 med
-10% discount
Net margin vs peers
2.9% / 0.5% med
above median
1–13 of 13
LFSTLifestance Health Group, Inc.$5.1B100.163.203.2%-1.08%
PRVAPrivia Health Group, Inc.$2.7B96.601.151.2%-0.98%
WGSGenedx Holdings Corp.$1.9B—4.21-23.4%-7.17%
PNTGPennant Group, Inc.$1.4B43.841.292.9%-2.73%
USPHU S Physical Therapy Inc /Nv$1.3B39.391.564.0%-0.65%
INNVInnovAge Holding Corp.$1.2B—1.23-0.3%-2.94%
OMDAOmada Health, Inc.$1.1B253.973.531.4%-4.77%
ALPSAlps Group Inc$53M———-2.14%
EUDAEUDA Health Holdings Ltd$30M—4.40-40.7%-9.52%
DCGODocGo Inc.$21M—0.07-65.3%-14.63%
PIIIP3 Health Partners Inc.$13M—0.01-10.1%-7.10%
ATPCAgape ATP Corp$1M———-12.67%
PIIIWP3 Health Partners Inc.————-16.00%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.